These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23653274)

  • 1. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
    Chojnacki C; Walecka-Kapica E; Lokieć K; Pawłowicz M; Winczyk K; Chojnacki J; Klupińska G
    Endokrynol Pol; 2013; 64(2):114-20. PubMed ID: 23653274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome.
    Wisniewska-Jarosinska M; Chojnacki J; Konturek S; Brzozowski T; Smigielski J; Chojnacki C
    J Physiol Pharmacol; 2010 Jun; 61(3):295-300. PubMed ID: 20610859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is melatonin involved in the irritable bowel syndrome?
    Radwan P; Skrzydlo-Radomanska B; Radwan-Kwiatek K; Burak-Czapiuk B; Strzemecka J
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():67-70. PubMed ID: 19996484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Melatonin secretion and metabolism in patients with irritable bowel syndrome].
    Stepień A; Moskwa-Fortuna A; Wisniewska-Jarosińska M; Harasiuk A; Chojnacki J
    Pol Merkur Lekarski; 2009 May; 26(155):440-3. PubMed ID: 19606692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome.
    Chojnacki C; Walecka-Kapica E; Mokwinska M; Romanowski M; Pawlowicz M; Chojnacki J; Klupinska G
    J Physiol Pharmacol; 2013 Apr; 64(2):177-83. PubMed ID: 23756392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
    Faghih Dinevari M; Jafarzadeh F; Jabbaripour Sarmadian A; Abbasian S; Nikniaz Z; Riazi A
    BMC Gastroenterol; 2023 Apr; 23(1):135. PubMed ID: 37098505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
    Tegaserod Clinical Research Group
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
    World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
    Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome.
    Saito YA; Almazar AE; Tilkes KE; Choung RS; Van Norstrand MD; Schleck CD; Zinsmeister AR; Talley NJ
    Aliment Pharmacol Ther; 2019 Feb; 49(4):389-397. PubMed ID: 30663077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study.
    Pimentel M; Chatterjee S; Chow EJ; Park S; Kong Y
    Dig Dis Sci; 2006 Aug; 51(8):1297-301. PubMed ID: 16832617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF; Miner PB; Fischer L; Harris MS
    Aliment Pharmacol Ther; 2011 Oct; 34(8):868-77. PubMed ID: 21883322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome.
    Chapman RW; Stanghellini V; Geraint M; Halphen M
    Am J Gastroenterol; 2013 Sep; 108(9):1508-15. PubMed ID: 23835436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation.
    Chang L; Chey WD; Drossman D; Losch-Beridon T; Wang M; Lichtlen P; Mareya S
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1114-1122. PubMed ID: 27669680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
    Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
    N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.